Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | THPO | P40225 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.96 |
| ▸ | FYN | P06241 | 2/20 | 0.71 |
| ▸ | DRD2 | P14416 | 4/20 | 0.63 |
| ▸ | DRD3 | P35462 | 3/20 | 0.63 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.63 |
| ▸ | DRD1 | P21728 | 1/20 | 0.53 |
| ▸ | PLAU | P00749 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7395494 | 1.00 | MAPT (1.00) | MAPTNFKB1THPOHIF1AHSD17B10 | |
| SCHEMBL3126243 | 1.00 | MAPT (1.00) | MAPTNFKB1THPOHIF1AHSD17B10 | |
| SCHEMBL29602850 | 1.00 | MAPT (1.00) | MAPTNFKB1THPOHIF1AHSD17B10 | |
| Hydrochloric Acid SCHEMBL7922003 | 0.98 | MAPT (0.96) | MAPTNFKB1THPOHIF1AHSD17B10 | |
| Bromide SCHEMBL7364104 | 0.98 | MAPT (1.00) | MAPTNFKB1THPOHIF1AHSD17B10 | |
| Bromide SCHEMBL3763048 | 0.98 | MAPT (1.00) | MAPTNFKB1THPOHIF1AHSD17B10 | |
| Hydrochloric Acid SCHEMBL7922007 | 0.98 | MAPT (0.96) | MAPTNFKB1THPOHIF1AHSD17B10 | |
| Bromide SCHEMBL29634886 | 0.98 | MAPT (1.00) | MAPTNFKB1THPOHIF1AHSD17B10 | |
| Hydrochloric Acid SCHEMBL11042661 | 0.87 | MAPT (0.76) | MAPTNFKB1THPOHIF1AHSD17B10 | |
| Hydrochloric Acid SCHEMBL11046771 | 0.87 | MAPT (0.76) | MAPTNFKB1THPOHIF1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1017377-B1 | USE OF 6, 7-SUBSTITUTED 2-AMINOTETRALINES FOR THE TREATMENT OF CYTOKINE MEDIATED INFLAMMATORY CONDITIONS | SIGMA TAU IND BR FARMACEUTICHE (IT) | 2001-12-05 | — | — | EP | claimed |
| JP-2001517618-A | — | — | 2001-10-09 | — | — | JP | claimed |
| EP-1017377-A2 | USE OF 6, 7-SUBSTITUTED 2-AMINOTETRALINES FOR THE TREATMENT OF CYTOKINE MEDIATED INFLAMMATORY CONDITIONS | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2000-07-12 | — | — | EP | claimed |
| WO-1999015160-A2 | USE OF 6,7-SUBSTITUTED 2-AMINOTETRALINES SUITABLE FOR PREPARING PHARMACEUTICAL COMPOSITION FOR THE THERAPEUTIC TREATMENT OF INFLAMMATORY AND/OR AUTOIMMUNE PATHOLOGIES | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1999-04-01 | — | — | WO | claimed |